
PGNY — Progyny Inc
NASDAQ · Healthcare · Healthcare Plans
$26.36
+$0.70 (+2.73%)
Progyny Inc (PGNY) is a healthcare plans company listed on NASDAQ. It is led by Peter Anevski CPA, based in 1359 Broadway, New York, NY, United States, 10018, with about 675 employees. Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Latest reported PGNY revenue for 2025-09-30 was $313.3M. Net income was $46.0M. Revenue was down 5.9% from 2025-06-30 to 2025-09-30. PGNY currently screens at market cap $1.84B and trailing P/E 37.6.
Use this PGNY page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PGNY quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PGNY SEC filings page. Lician reads the product cache first so this HTML stays unique to Progyny Inc even when a live quote feed is slow.
About Progyny Inc
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
PGNY Key Statistics
Market Cap
$1.84B
Volume
814,697
Previous Close
$25.65
Day Range
$25.34 – $25.89
P/E Ratio
37.65
EPS
$0.12
Revenue
$298.43M
Net Income
$54.34M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+10.6%
Profit Margin
18.2%
Employees
675
PGNY Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 |
|---|---|---|
| Revenue | $298.43M | $269.94M |
| Cost of Revenue | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 |
| Net Income | $54.34M | $62.04M |
| EPS (Diluted) | $0.12 | $0.13 |
Total Assets
$607.10M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$162.31M
Operating Cash Flow
$179.10M
Free Cash Flow
$0.00
Progyny Inc Company Information
- CEO & Director
- Peter Anevski CPA
- Headquarters
- 1359 Broadway, New York, NY, United States, 10018
- Website
- www.progyny.com
- Phone
- 212 888 3124
- IPO / Founded
- 2019-10-25
- Sector
- Healthcare
- Industry
- Healthcare Plans